AAAAAA
Results:
1-12
|
Results: 12
Authors:
Prior, JC
Kirkland, SA
Joseph, L
Kreiger, N
Murray, TM
Hanley, DA
Adachi, JD
Vigna, YM
Berger, C
Blondeau, L
Jackson, SA
Tenenhouse, A
Citation: Jc. Prior et al., Oval contraceptive use and bone mineral density in premenopausal women: cross-sectional, population-based data from the Canadian Multicentre Osteoporosis Study, CAN MED A J, 165(8), 2001, pp. 1023-1029
Authors:
Lindsay, R
Silverman, SL
Cooper, C
Hanley, DA
Barton, I
Broy, SB
Licata, A
Benhamou, L
Geusens, P
Flowers, K
Stracke, H
Seeman, E
Citation: R. Lindsay et al., Risk of new vertebral fracture in the year following a fracture, J AM MED A, 285(3), 2001, pp. 320-323
Authors:
Hanley, DA
Mather, KJ
Meddings, JB
Beck, PL
Scott, RB
Citation: Da. Hanley et al., Screening for celiac disease in idiopathic osteoporosis - Response, AM J GASTRO, 96(11), 2001, pp. 3204-3204
Authors:
Mather, KJ
Meddings, JB
Beck, PL
Scott, RB
Hanley, DA
Citation: Kj. Mather et al., Prevalence of IgA-antiendomysial antibody in asymptomatic low bone mineraldensity, AM J GASTRO, 96(1), 2001, pp. 120-125
Authors:
Hanley, DA
Ioannidis, G
Adachi, JD
Citation: Da. Hanley et al., Etidronate therapy in the treatment and prevention of osteoporosis, J CLIN DENS, 3(1), 2000, pp. 79-95
Authors:
Crilly, RG
Sebaldt, RJ
Hodsman, AB
Adachi, JD
Brown, JP
Goldsmith, CH
Hanley, DA
Olszynski, WO
Ste-Marie, LG
Stephenson, GF
Citation: Rg. Crilly et al., Predicting subsequent bone density response to intermittent cyclical therapy with etidronate from initial density response in patients with osteoporosis, OSTEOPOR IN, 11(7), 2000, pp. 607-614
Authors:
Tenenhouse, A
Joseph, L
Kreiger, N
Poliquin, S
Murray, TM
Blondeau, L
Berger, C
Hanley, DA
Prior, JC
Citation: A. Tenenhouse et al., Estimation of the prevalence of low bone density in Canadian women and menusing a population-specific DXA reference standard: The Canadian Multicentre osteoporosis study (CaMos), OSTEOPOR IN, 11(10), 2000, pp. 897-904
Authors:
Hopman, WM
Towheed, T
Anastassiades, T
Tenenhouse, A
Poliquin, S
Berger, C
Joseph, L
Brown, JP
Murray, TM
Adachi, JD
Hanley, DA
Papadimitropoulos, E
Citation: Wm. Hopman et al., Canadian normative data for the SF-36 health survey, CAN MED A J, 163(3), 2000, pp. 265-271
Authors:
Adachi, JD
Olszynski, WP
Hanley, DA
Hodsman, AB
Kendler, DL
Siminoski, KG
Brown, J
Cowden, EA
Goltzman, D
Ioannidis, G
Josse, RG
Ste-Marie, LG
Tenenhouse, AM
Davison, KS
Blocka, KLN
Pollock, AP
Sibley, J
Citation: Jd. Adachi et al., Management of corticosteroid-induced osteoporosis, SEM ARTH RH, 29(4), 2000, pp. 228-251
Authors:
Rittmaster, RS
Bolognese, M
Ettinger, MP
Hanley, DA
Hodsman, AB
Kendler, DL
Rosen, CJ
Citation: Rs. Rittmaster et al., Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate, J CLIN END, 85(6), 2000, pp. 2129-2134
Authors:
Pols, HAP
Felsenberg, D
Hanley, DA
Stepan, J
Munoz-Torres, M
Wilkin, TJ
Qin-sheng, G
Galich, AM
Vandormael, K
Yates, AJ
Stych, B
Citation: Hap. Pols et al., Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: Results of the FOSIT study, OSTEOPOR IN, 9(5), 1999, pp. 461-468
Authors:
Hargrove, GM
Pasieka, JL
Hanley, DA
Murphy, MB
Citation: Gm. Hargrove et al., Short- and long-term outcome of total parathyroidectomy with immediate autografting versus subtotal parathyroidectomy in patients with end-stage renal disease, AM J NEPHR, 19(5), 1999, pp. 559-564
Risultati:
1-12
|